연구성과로 돌아가기
2022 연구성과별 연구자 정보 (1428 / 2879)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B | Ahn, Sang Bong | Ahn, SB | 14 | Eulji Univ, Coll Med, Nowon Eulji Med Ctr, Dept Internal Med, Seoul, South Korea | pindra@empal.com;gepapath@med.uoa.gr; | |||||
| Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B | Shim, Jae-Jun | Shim, JJ | 15 | Kyung Hee Univ, Sch Med, Dept Internal Med, Seoul, South Korea | pindra@empal.com;gepapath@med.uoa.gr; | |||||
| Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B | Jeong, Soung Won | Jeong, SW | 16 | Soonchunhyang Univ, Soonchunhyang Univ Seoul Hosp, Dept Internal Med, Coll Med, Seoul, South Korea | pindra@empal.com;gepapath@med.uoa.gr; | |||||
| Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B | Cho, Yong Kyun | Cho, YK | 17 | Sungkyunkwan Univ, Kangbuk Samsung Hosp, Sch Med, Dept Internal Med, Seoul, South Korea | pindra@empal.com;gepapath@med.uoa.gr; | |||||
| Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B | Kim, Hyoung Su | Kim, HS | 18 | Hallym Univ, Kangdong Sacred Heart Hosp, Coll Med, Dept Internal Med, Seoul, South Korea | pindra@empal.com;gepapath@med.uoa.gr; | |||||
| Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B | Nam, Joon Yeul | Nam, JY | 19 | Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea | pindra@empal.com;gepapath@med.uoa.gr; | |||||
| Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B | Nam, Joon Yeul | Nam, JY | 19 | Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea | pindra@empal.com;gepapath@med.uoa.gr; | |||||
| Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B | Lee, Yun Bin | Lee, YB | 20 | Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea | AAH-8473-2020 | Lee, Hyun Woo | pindra@empal.com;gepapath@med.uoa.gr; | |||
| Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B | Lee, Yun Bin | Lee, YB | 20 | Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea | AAH-8473-2020 | Lee, Hyun Woo | pindra@empal.com;gepapath@med.uoa.gr; | |||
| Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B | Kim, Yoon Jun | Kim, YJ | 21 | Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea | J-2746-2012 | Kim, Yoon | pindra@empal.com;gepapath@med.uoa.gr; | |||
| Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B | Kim, Yoon Jun | Kim, YJ | 21 | Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea | J-2746-2012 | Kim, Yoon | pindra@empal.com;gepapath@med.uoa.gr; | |||
| Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B | Yoon, Jung-Hwan | Yoon, JH | 22 | Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea | J-5563-2012 | Yoon, Jung | pindra@empal.com;gepapath@med.uoa.gr; | |||
| Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B | Yoon, Jung-Hwan | Yoon, JH | 22 | Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea | J-5563-2012 | Yoon, Jung | pindra@empal.com;gepapath@med.uoa.gr; | |||
| Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B | Zoulim, Fabien | Zoulim, F | 23 | Lyon Univ, Hosp Civils Lyon, Canc Res Ctr Lyon, INSERM U, Lyon, France | 0000-0002-2245-0083 | Zoulim, Fabien | pindra@empal.com;gepapath@med.uoa.gr; | |||
| Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B | Lampertico, Pietro | Lampertico, P | 24 | Fdn IRCCS Ca Granda Osped Maggiore Policlin, Div Gastroenterol & Hepatol, Milan, Italy | J-8463-2018 | Lampertico, Pietro | pindra@empal.com;gepapath@med.uoa.gr; |
페이지 이동: